244 related articles for article (PubMed ID: 19587552)
1. Defining blood pressure goals: is it enough to manage total cardiovascular risk?
Mancia G
J Hypertens Suppl; 2009 Jul; 27(5):S3-8. PubMed ID: 19587552
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study.
Sega R; Facchetti R; Bombelli M; Cesana G; Corrao G; Grassi G; Mancia G
Circulation; 2005 Apr; 111(14):1777-83. PubMed ID: 15809377
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values.
Bombelli M; Facchetti R; Carugo S; Madotto F; Arenare F; Quarti-Trevano F; Capra A; Giannattasio C; Dell'Oro R; Grassi G; Sega R; Mancia G
J Hypertens; 2009 Dec; 27(12):2458-64. PubMed ID: 19654559
[TBL] [Abstract][Full Text] [Related]
4. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure.
Mancia G; Facchetti R; Bombelli M; Grassi G; Sega R
Hypertension; 2006 May; 47(5):846-53. PubMed ID: 16567588
[TBL] [Abstract][Full Text] [Related]
5. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality.
Bombelli M; Ronchi I; Volpe M; Facchetti R; Carugo S; Dell'oro R; Cuspidi C; Grassi G; Mancia G
J Hypertens; 2014 Jun; 32(6):1237-44. PubMed ID: 24675682
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: data from the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni.
Mancia G; Carugo S; Grassi G; Lanzarotti A; Schiavina R; Cesana G; Sega R;
Hypertension; 2002 Mar; 39(3):744-9. PubMed ID: 11897756
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
[TBL] [Abstract][Full Text] [Related]
9. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
[TBL] [Abstract][Full Text] [Related]
10. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals.
; ; ; ; ; Hermida RC; Smolensky MH; Ayala DE; Portaluppi F
Chronobiol Int; 2013 Apr; 30(3):355-410. PubMed ID: 23517220
[TBL] [Abstract][Full Text] [Related]
11. Ambulatory blood pressure monitoring: is it mandatory for blood pressure control in treated hypertensive patients?: prospective observational study.
Lehmann MV; Zeymer U; Dechend R; Kaiser E; Hagedorn I; Deeg E; Senges J; Schmieder RE
Int J Cardiol; 2013 Oct; 168(3):2255-63. PubMed ID: 23474245
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure variability over 24 h: prognostic implications and treatment perspectives. An assessment using the smoothness index with telmisartan-amlodipine monotherapy and combination.
Parati G; Schumacher H
Hypertens Res; 2014 Mar; 37(3):187-93. PubMed ID: 24305518
[TBL] [Abstract][Full Text] [Related]
13. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
Hermida RC
Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the effects of fixed dose vs. single-agent combinations on 24-h blood pressure variability.
Ulusoy S; Ozkan G; Konca C; Kaynar K
Hypertens Res; 2012 Nov; 35(11):1111-7. PubMed ID: 22786565
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: data from the Pressioni Arteriose Monitorate E Loro Associazioni study.
Bombelli M; Maloberti A; Raina L; Facchetti R; Boggioni I; Pizzala DP; Cuspidi C; Mancia G; Grassi G
J Hypertens; 2016 Sep; 34(9):1823-30. PubMed ID: 27348518
[TBL] [Abstract][Full Text] [Related]
16. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
Hermida RC; Ayala DE; Fernández JR; Mojón A
Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
[TBL] [Abstract][Full Text] [Related]
17. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study.
Mancia G; Parati G; Bilo G; Choi J; Kilama MO; Ruilope LM;
J Hypertens; 2011 Mar; 29(3):600-9. PubMed ID: 21252701
[TBL] [Abstract][Full Text] [Related]
19. Role of time-of-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):328-39. PubMed ID: 23181738
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in resistant hypertension: implications for cardiovascular risk stratification and therapeutic management.
de Souza F; Muxfeldt ES; Salles GF
Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):735-45. PubMed ID: 22894630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
